These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 6696129)
21. Arachidonic acid in splanchnic artery occlusion shock. Bridenbaugh GA; Flynn JT; Lefer AM Am J Physiol; 1976 Jul; 231(1):112-9. PubMed ID: 961849 [TBL] [Abstract][Full Text] [Related]
22. Salutary effects of prostacyclin in endotoxic shock. Lefer AM; Tabas J; Smith EF Pharmacology; 1980; 21(3):206-12. PubMed ID: 6997895 [TBL] [Abstract][Full Text] [Related]
23. Effect of arginine vasopressin on vascular reactivity and calcium sensitivity after hemorrhagic shock in rats and its relationship to Rho-kinase. Yang G; Liu L; Xu J; Li T J Trauma; 2006 Dec; 61(6):1336-42. PubMed ID: 17159674 [TBL] [Abstract][Full Text] [Related]
24. Salutary consequences of blockade of platelet activating factor in hemorrhagic shock. Stahl GL; Bitterman H; Terashita Z; Lefer AM Eur J Pharmacol; 1988 May; 149(3):233-40. PubMed ID: 3409951 [TBL] [Abstract][Full Text] [Related]
25. Shock potentiating actions of angiotensin II infusion in cats. Trachte GJ; Lefer AM Circ Shock; 1980; 7(3):343-51. PubMed ID: 7449049 [TBL] [Abstract][Full Text] [Related]
26. Effects of adenosine, an adenosine-A1 antagonist, and their combination in splanchnic occlusion shock in rats. Karasawa A; Rochester JA; Lefer AM Circ Shock; 1992 Feb; 36(2):154-61. PubMed ID: 1582007 [TBL] [Abstract][Full Text] [Related]
27. Beneficial actions of RO 15-1788, a benzodiazepine receptor antagonist, in hemorrhagic shock. Bitterman H; Lefer DJ; Lefer AM Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):341-7. PubMed ID: 3116357 [TBL] [Abstract][Full Text] [Related]
28. Mechanisms of action of PGE1 in hemorrhagic shock in rats. Bitterman H; Stahl GL; Terashita Z; Lefer AM Ann Emerg Med; 1988 May; 17(5):457-62. PubMed ID: 3364825 [TBL] [Abstract][Full Text] [Related]
29. Salutary effects of anisodamine in murine traumatic shock. Hock CE; Su JY; Lefer AM Circ Shock; 1983; 11(3):211-6. PubMed ID: 6652878 [TBL] [Abstract][Full Text] [Related]
31. Beneficial effects of transforming growth factor-beta and tissue plasminogen activator in splanchnic artery occlusion and reperfusion in cats. Karasawa A; Guo JP; Ma XL; Lefer AM J Cardiovasc Pharmacol; 1991 Jul; 18(1):95-105. PubMed ID: 1719297 [TBL] [Abstract][Full Text] [Related]
32. Amelioration of splanchnic artery occlusion (SAO) shock by cysteine. Galvin MJ; Lefer AM Adv Shock Res; 1978; 1():261-70. PubMed ID: 262085 [No Abstract] [Full Text] [Related]
33. Release of prostaglandin F2alpha during splanchnic artery occlusion shock. Flynn JT; Bridenbaugh GA; Lefer AM Am J Physiol; 1976 Mar; 230(3):684-90. PubMed ID: 1266970 [TBL] [Abstract][Full Text] [Related]
34. Evidence for a role of platelet activating factor in hypovolemic shock in the rat. Zingarelli B; Squadrito F; Bussolino F; Calapai G; Altavilla D; Ioculano M; Campo GM; Canale P; Caputi AP J Lipid Mediat Cell Signal; 1994 Mar; 9(2):123-34. PubMed ID: 8012759 [TBL] [Abstract][Full Text] [Related]
35. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats. Tarpey SB; Bennett T; Randall MD; Gardiner SM Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732 [TBL] [Abstract][Full Text] [Related]
36. Arginine vasopressin: the future of pressure-support resuscitation in hemorrhagic shock. Anand T; Skinner R J Surg Res; 2012 Nov; 178(1):321-9. PubMed ID: 22480832 [TBL] [Abstract][Full Text] [Related]
37. Beneficial effects of two forms of NO administration in feline splanchnic artery occlusion shock. Aoki N; Johnson G; Lefer AM Am J Physiol; 1990 Feb; 258(2 Pt 1):G275-81. PubMed ID: 2305894 [TBL] [Abstract][Full Text] [Related]
38. Novel mechanism of action of a prostacyclin enhancing agent in haemorrhagic shock. Bitterman H; Lefer DJ; Lefer AM Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):679-86. PubMed ID: 3063971 [TBL] [Abstract][Full Text] [Related]
39. Supplemental arginine vasopressin during the resuscitation of severe hemorrhagic shock preserves renal mitochondrial function. Sims CA; Yuxia G; Singh K; Werlin EC; Reilly PM; Baur JA PLoS One; 2017; 12(10):e0186339. PubMed ID: 29065123 [TBL] [Abstract][Full Text] [Related]
40. Beneficial effects of combined thromboxane and leukotriene receptor antagonism in hemorrhagic shock. Patel JP; Beck LD; Briglia FA; Hock CE Crit Care Med; 1995 Feb; 23(2):231-7. PubMed ID: 7867347 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]